Rongcai Jiang

Summary

Country: China

Publications

  1. Xu X, Yin D, Ren H, Gao W, Li F, Sun D, et al. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiol Dis. 2018;117:15-27 pubmed publisher
  2. Jiang R, Wang D, Poon W, Lu Y, Li X, Zhao S, et al. Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial. Trials. 2015;16:528 pubmed publisher
    ..ClinicalTrials.gov Identifier--NCT02024373 The date of trial registration: 7 August 2013. ..
  3. Wang D, Li T, Wei H, Wang Y, Yang G, Tian Y, et al. Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model. J Neurol Sci. 2016;362:91-9 pubmed publisher
    ..The low-dose atorvastatin is effective in reducing SDH and improving neurological deficits in a rat model, primarily by promoting angiogenesis and vascular maturation. ..
  4. Gao C, Qian Y, Huang J, Wang D, Su W, Wang P, et al. A Three-Day Consecutive Fingolimod Administration Improves Neurological Functions and Modulates Multiple Immune Responses of CCI Mice. Mol Neurobiol. 2017;54:8348-8360 pubmed publisher
  5. Su W, Gao C, Wang P, Huang J, Qian Y, Guo L, et al. Correlation of Circulating T Lymphocytes and Intracranial Hypertension in Intracerebral Hemorrhage. World Neurosurg. 2017;107:389-395 pubmed publisher
    ..003, AUCĀ = 0.812). The CD4+/CD8+ T lymphocyte ratio may be a valuable indicator for predicting postoperative ICP and the short-term prognosis after ICH. ..
  6. Xu X, Gao W, Cheng S, Yin D, Li F, Wu Y, et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J Neuroinflammation. 2017;14:167 pubmed publisher